The Filing Desk

CapsoVision vs Nexgel

CapsoVision CV · Nexgel NXGL · Health Care Equipment

CapsoVision reported revenue of $14 million in fiscal 2025, 1.2 times Nexgel's $11 million in fiscal 2025. CapsoVision's revenue grew 15.3% in its latest year, and Nexgel's grew 31.5%. CapsoVision had an operating margin of -188.2%, against -29.4% at Nexgel. Free cash flow was −$23 million at CapsoVision and −$1 million at Nexgel.

Side by side

CapsoVisionNexgel
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$14M$11M
Revenue growth15.3%31.5%
Revenue growth a year, last 5 years—74.7%
Gross margin52.9%39.5%
Operating margin−188.2%−29.4%
Net margin−186.8%−26.3%
Free cash flow−$23M−$1M
Free cash flow margin−169.3%−12.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count1,115.6%20.6%
Last close$6.31$3.35
P/E at the last close——
Insider trades, last 12 monthsbought $16.0 million, sold $0—
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CapsoVisionNexgel
Operating margin
Percent of revenue
CapsoVisionNexgel
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CapsoVisionNexgel

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CapsoVision and Nexgel pages.